EssilorLuxottica Income After Taxes 2012-2025 | ESLOY
EssilorLuxottica annual/quarterly income after taxes history and growth rate from 2012 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- EssilorLuxottica income after taxes for the quarter ending December 31, 2025 was $0M, a 0% increase year-over-year.
- EssilorLuxottica income after taxes for the twelve months ending December 31, 2025 was $0M, a 0% increase year-over-year.
- EssilorLuxottica annual income after taxes for 2025 was $2.764B, a 2.54% increase from 2024.
- EssilorLuxottica annual income after taxes for 2024 was $2.696B, a 2.66% increase from 2023.
- EssilorLuxottica annual income after taxes for 2023 was $2.626B, a 9.25% increase from 2022.
|
EssilorLuxottica Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2025 | $2,764 |
| 2024 | $2,696 |
| 2023 | $2,626 |
| 2022 | $2,403 |
| 2021 | $1,908 |
| 2020 | $170 |
| 2019 | $1,326 |
| 2018 | $1,365 |
| 2017 | $992 |
| 2016 | $974 |
| 2015 | $903 |
| 2014 | $1,311 |
| 2013 | $858 |
| 2012 | $811 |
| 2011 | $722 |
|
EssilorLuxottica Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2025-12-31 | |
| 2025-06-30 | |
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2015-12-31 | |
| 2015-06-30 | |
| 2014-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $94.632B | $32.227B |
| EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $153.994B | 16.97 |
| Stryker (SYK) | United States | $117.998B | 22.99 |
| Medtronic (MDT) | Ireland | $101.863B | 14.35 |
| Boston Scientific (BSX) | United States | $67.317B | 14.61 |
| Medline (MDLN) | United States | $47.214B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.980B | 0.00 |
| Agilent Technologies (A) | United States | $35.886B | 21.87 |
| GE HealthCare Technologies (GEHC) | United States | $28.017B | 13.51 |
| ResMed (RMD) | United States | $27.362B | 17.51 |
| Koninklijke Philips (PHG) | Netherlands | $26.322B | 15.30 |
| Terumo (TRUMY) | Japan | $20.651B | 22.95 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.019B | 10.37 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.787B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.510B | 0.00 |
| Baxter (BAX) | United States | $10.273B | 9.56 |
| Insulet (PODD) | United States | $10.096B | 27.09 |
| Demant (WILYY) | Denmark | $8.153B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.559B | 30.47 |
| Lantheus Holdings (LNTH) | United States | $6.762B | 20.85 |
| BillionToOne (BLLN) | United States | $4.836B | 0.00 |
| Envista Holdings (NVST) | United States | $4.216B | 19.63 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.062B | 0.00 |
| ICU Medical (ICUI) | United States | $3.508B | 22.11 |
| Haemonetics (HAE) | United States | $3.371B | 14.92 |
| Curaleaf Holdings (CURLD) | Canada | $2.345B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.225B | 10.70 |
| LeMaitre Vascular (LMAT) | United States | $2.147B | 36.42 |
| GN Store Nord (GNNDY) | Denmark | $2.047B | 96.90 |
| Neogen (NEOG) | United States | $2.027B | 44.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.951B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.644B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.590B | 17.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| AtriCure (ATRC) | United States | $1.458B | 960.00 |
| Perrigo (PRGO) | Ireland | $1.418B | 3.99 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.312B | 33.28 |
| Phibro Animal Health (PAHC) | United States | $1.292B | 10.87 |
| BioLife Solutions (BLFS) | United States | $1.272B | 217.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.163B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.932B | 10.20 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.849B | 9.71 |
| Omeros (OMER) | United States | $0.744B | 4.72 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Brainsway (BWAY) | Israel | $0.597B | 42.54 |
| Tilray Brands (TLRY) | Canada | $0.551B | 0.00 |
| Cerus (CERS) | United States | $0.541B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.503B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.443B | 11.08 |
| Evolus (EOLS) | United States | $0.437B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.417B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.408B | 28.76 |
| Cresco Labs (CRLBF) | United States | $0.407B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.391B | 0.00 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 17.46 |
| OraSure Technologies (OSUR) | United States | $0.293B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Accendra Health (ACH) | United States | $0.247B | 4.75 |
| Village Farms (VFF) | Canada | $0.218B | 8.68 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.214B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.213B | 19.83 |
| High Tide (HITI) | Canada | $0.203B | 57.75 |
| Sanara MedTech (SMTI) | United States | $0.202B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.180B | 48.83 |
| Apyx Medical (APYX) | United States | $0.172B | 0.00 |
| Quanterix (QTRX) | United States | $0.160B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.159B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Organigram Global (OGI) | Canada | $0.136B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Exagen (XGN) | United States | $0.110B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.106B | 14.27 |
| Jushi Holdings (JUSHF) | United States | $0.096B | 0.00 |
| ImmuCell (ICCC) | United States | $0.086B | 0.00 |
| Biote (BTMD) | United States | $0.085B | 5.14 |
| Hongchang (HCIL) | China | $0.081B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.079B | 27.91 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.051B | 0.00 |
| Veru (VERU) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.034B | 45.00 |
| United-Guardian (UG) | United States | $0.032B | 13.54 |
| Cytosorbents (CTSO) | United States | $0.028B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.025B | 0.00 |
| Modular Medical (MODD) | United States | $0.024B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Jin Medical (ZJYL) | China | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.013B | 0.00 |
| Akanda (AKAN) | Canada | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| INLIF (INLF) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |